Skip to main content
AVACTA GROUP PLC logo

AVACTA GROUP PLC — Investor Relations & Filings

Ticker · AVCT ISIN · GB00BYYW9G87 LEI · 2138009U3EG31OPMGH36 IL Manufacturing
Open in API
Filings indexed 708 across all filing types
Latest filing 2020-12-23 Regulatory Filings
Country GB United Kingdom
Listing IL AVCT

About AVACTA GROUP PLC

https://avacta.com/

Avacta Group PLC is a clinical-stage biotechnology company developing targeted oncology drugs. The company's core technology is the proprietary pre|CISION® platform, a drug delivery system designed to improve the safety and efficacy of potent cancer therapies. The platform works by linking a peptide to a cancer drug, rendering it inactive in the bloodstream. The drug is precisely activated only within the tumor microenvironment by the Fibroblast Activation Protein (FAP) enzyme, which is abundant in many solid tumors. This approach aims to concentrate the active therapy at the tumor site, thereby reducing systemic toxicity and improving the therapeutic window for patients. The company is advancing a pipeline of peptide drug conjugates (PDCs) based on this platform.

Recent filings

Filing Released Lang Actions
Submission of CTA for AVA6000 Pro-doxorubixin
Regulatory Filings Classification · 100% confidence The document begins with 'RNS Number : 6025J' and is dated '23 December 2020'. The content announces the 'Submission of Clinical Trial Application (CTA) in the UK for a Phase 1... study of its lead pre|CISIONTM prodrug, AVA6000'. This is a specific corporate announcement regarding regulatory/clinical progress, not a full financial report (like 10-K or IR) or a general earnings release (ER). Since it is a formal announcement distributed via RNS (the news service of the London Stock Exchange) and concerns a specific operational/regulatory event (CTA submission), it fits best under the general 'Regulatory Filings' category (RNS) as a specific operational update that doesn't match the other specialized codes like CAP, LTR, or DIV. It is not a Report Publication Announcement (RPA) because it is the substance of the announcement itself, not just a notice that a report is available.
2020-12-23 English
License Agreement with Astrea Bioseparations
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and is dated '21 December 2020'. It announces a specific corporate event: entering into a 'License Agreement with Astrea Bioseparations' regarding the Affimer platform, including financial details (£0.5 million upfront payment) and strategic commentary. RNS (Regulatory News Service) filings are typically used for immediate, material announcements that must be disclosed to the market. This announcement is not a full annual report (10-K), an interim report (IR), an earnings release (ER), or a proxy statement (DEF 14A/PSI). It is a specific corporate development announcement. Since it is a formal regulatory announcement distributed via RNS, and it details a business transaction (licensing deal), it fits best under the general 'Regulatory Filings' category (RNS) as a catch-all for material, non-standard announcements, or potentially 'Capital/Financing Update' (CAP) if the focus was purely on the cash inflow, but RNS is more appropriate for the nature of the distribution channel and the content type (a specific deal announcement). Given the structure and the explicit mention of RNS, the most fitting code is RNS.
2020-12-21 English
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document is very short (1934 characters) and contains the header 'RNS Number : 1561G' and mentions 'RNS, the news service of the London Stock Exchange'. The content describes a 'Second Price Monitoring Extension' related to trading activity, which is a specific, non-financial report announcement. Since it is a regulatory announcement distributed via the RNS system and does not fit into the specific categories like ER, IR, or 10-K, it falls best under the general regulatory announcement category, RNS. It is not an announcement of a report publication (RPA) but a direct regulatory notice.
2020-11-23 English
Price Monitoring Extension
Regulatory Filings Classification · 99% confidence The document is very short (1917 characters) and contains the header 'RNS Number : 1551G'. It announces a 'Price Monitoring Extension' for a security, which is a specific, short-form operational update related to trading mechanisms on the London Stock Exchange. It explicitly states that the information is provided by RNS, the news service of the London Stock Exchange, and is approved by the Financial Conduct Authority (FCA) as a Primary Information Provider. This type of brief, regulatory-mandated operational announcement that doesn't fit into specific financial reporting categories (like 10-K, ER, or DIV) is best classified as a general Regulatory Filing or announcement, which corresponds to the RNS code.
2020-11-23 English
SARS-CoV-2 Rapid Antigen Test Update
Regulatory Filings Classification · 98% confidence The document begins with 'RNS Number' and contains information typically disseminated via the Regulatory News Service (RNS) of the London Stock Exchange. It provides an update on the development of a SARS-CoV-2 Rapid Antigen Test, which is a material operational update for the company. The content is a formal announcement intended for the market, not a full financial report (like 10-K or IR) or a transcript. Since it is a general regulatory announcement that doesn't fit perfectly into the more specific categories like ER, DIV, or CAP, the most appropriate classification is the general regulatory filing category, RNS.
2020-11-23 English
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document is very short (1934 characters) and begins with 'RNS Number : 7850F' and mentions 'RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider'. The content describes a 'Second Price Monitoring Extension' related to trading activity, which is a specific, time-sensitive market announcement. This type of general regulatory announcement that doesn't fit into the specific financial reporting categories (like 10-K, ER, IR) is best classified under the general regulatory filing category, RNS (Regulatory News Service). It is not an announcement of a report publication (RPA) because it is reporting an event (price monitoring extension), not announcing the release of a separate document like an earnings report or annual report.
2020-11-18 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.